CAS 132201-33-3

(2R,3S)-N-Benzoyl-3-phenylisoserine

Formula: C₁₆H₁₅NO₄

InChI: InChI=1S/C16H15NO4/c18-14(16(20)21)13(11-7-3-1-4-8-11)17-15(19)12-9-5-2-6-10-12/h1-10,13-14,18H,(H,17,19)(H,20,21)/t13-,14+/m0/s1

InChI key: InChIKey=HYJVYOWKYPNSTK-UONOGXRCSA-N

SMILES: [C@@H](NC(=O)C1=CC=CC=C1)([C@H](C(O)=O)O)C2=CC=CC=C2

Synonyms:

• (2R,3S)-2-hydroxy-3-phenyl-3-[(phenylcarbonyl)amino]propanoic acid
• (2R,3S)-3-(Benzoylamino)-2-hydroxy-3-phenylpropanoic acid
• (2R,3S)-3-(Benzoylamino)-2-hydroxy-3-phenylpropionic acid
• (2R,3S)-N-Benzoyl-3-phenylisoserine
• (αR,βS)-β-(Benzoylamino)-α-hydroxybenzenepropanoic acid
• Benzenepropanoic acid, β-(benzoylamino)-α-hydroxy-, (αR,βS)-
• Benzenepropanoic acid, β-(benzoylamino)-α-hydroxy-, [R-(R*,S*)]-
• N-benzoyl-(3S,2R)-3-phenylisoserine
• benzenepropanoic acid, beta-(benzoylamino)-alpha-hydroxy-, (alphaR,betaS)-
• N-Benzoyl-(2R,3S)-3-phenylisoserine

N-Benzoyl-(2R,3S)-3-phenylisoserine

CAS: 132201-33-3

N-Benzoyl-(2R,3S)-3-phenylisoserine

Formula: C₁₆H₁₅NO₄

Purity: ≥98%, 10 mM in DMSO

Molecular weight: 285.29

Ref: 54-BUP11873

Benzenepropanoic acid, β-(benzoylamino)-α-hydroxy-, (αR,βS)-

CAS: 132201-33-3

Formula: C₁₆H₁₅NO₄

Purity: 97%

Color and Shape: Solid

Molecular weight: 285.2946

Ref: IN-DA0010DS

N-Benzoyl-(2R,3S)-3-phenylisoserine

CAS: 132201-33-3

Molecular weight: 285.29

Ref: 7W-GM1874

N-Benzoyl-(2R,3S)-3-phenylisoserine

CAS: 132201-33-3

Formula: C₁₆H₁₅NO₄

Purity: 95%~99%

Molecular weight: 285.299

Ref: BP-BP4345

(2R,3S)-3-(Benzoylamino)-2-hydroxy-3-phenylpropanoic Acid ((2R,3S)-N-Benzoyl-3-phenylisoserine)

Controlled Product

CAS: 132201-33-3

Formula: C₁₆H₁₅NO₄

Color and Shape: Neat

Molecular weight: 285.29

Ref: 86-MM1489.06

N-Benzoyl-(2R,3S)-3-phenylisoserine

CAS: 132201-33-3

N-Benzoyl-(2R,3S)-3-phenylisoserine (taxol side chain) is an intermediate in the preparation of potent anticancer drug Paclitaxel, used to study the location of

Formula: C₁₆H₁₅NO₄

Purity: 99.10%

Color and Shape: White Solid

Molecular weight: 285.29

Ref: TM-T7054

Paclitaxel Side Chain Impurity 1

CAS: 132201-33-3

Formula: C₁₆H₁₅NO₄

Molecular weight: 285.30

Ref: 4Z-P-2832

N-Benzoyl-(2R,3S)-3-phenylisoserine

CAS: 132201-33-3

N-Benzoyl-(2R,3S)-3-Phenylisoserine

Formula: C₁₆H₁₅NO₄

Purity: 97%

Molecular weight: 285.29

Ref: IN-DG41247

(2R,3S)-N-Benzoyl-3-phenyl Isoserine

Controlled Product

CAS: 132201-33-3

Impurity Paclitaxel Side Chain Impurity 1
Applications (2R,3S)-N-Benzoyl-3-phenylisoserine is an intermediate in the preparation of potent anticancer drug Paclitaxel (P132500) used to study the location of the binding sites. (2R,3S)-N-Benzoyl-3-phenylisoserine shows cytotoxic, antiviral and immunomodulatory activity. Paclitaxel Side Chain Impurity 1.
References Paal, K. et al.: Bioorg. Med. Chem., 15, 1323 (2007); Krawczyk, E. et al.: J. Pharm. Pharmacol., 57, 791 (2005);

Formula: C₁₆H₁₅NO₄

Color and Shape: Neat

Molecular weight: 285.29

Ref: TR-B208550

(2R,3S)-3-Benzamido-2-hydroxy-3-phenylpropanoic acid

CAS: 132201-33-3

Formula: C₁₆H₁₅NO₄

Purity: 98%

Molecular weight: 285.299

Ref: 10-F212819

Paclitaxel Impurity 52

CAS: 132201-33-3

Formula: C₁₆H₁₅NO₄

Molecular weight: 285.30

Ref: ST-EA-CP-P36012

N-Benzoyl-(2R,3S)-3-amino-2-hydroxy-3-phenyl-propionicacid

CAS: 132201-33-3

N-Benzoyl-(2R,3S)-3-amino-2-hydroxy-3-phenylpropionic acid (BAPA) is a substance that is used in the manufacture of various drugs. It is also a potent anticancer drug that can be used for the treatment of cancer. BAPA has been shown to be an effective chemotherapeutic agent against many types of cancer cells. This drug is synthesized through an asymmetric synthesis process and has been shown to have potent cytotoxic effects against cancer cells with low levels of glutathione peroxide reductase. BAPA also inhibits the growth of bacteria by hydrolyzing or oxidizing proteins or by binding to DNA and RNA.

Formula: C₁₆H₁₅NO₄

Purity: Min. 95%

Molecular weight: 285.29 g/mol

Ref: 3D-FB151111